Observed and predicted relapse rates in the treatment shortening study of Johnson et al [9].

Predictions were based on updated model parameters, a month 2 culture positive proportion of 0.005 (0.5%), and a sample size of N = 185 per arm. H = isoniazid; R = rifampin; Z = pyrazinamide; E = ethambutol.Observed and predicted relapse rates in the treatment shortening study of Johnson et al [9].预测结果基于更新后的模型参数、第2个月培养阳性率为0.005（即0.5%），且每组样本量为N=185。其中H代表异烟肼（isoniazid）、R代表利福平（rifampin）、Z代表吡嗪酰胺（pyrazinamide）、E代表乙胺丁醇（ethambutol）。本数据集收录了约翰逊等人（Johnson et al）[9]开展的疗程缩短研究中的观测复发率与预测复发率。